Results 51 to 60 of about 19,838 (252)
The first Australian evidence‐based guidelines on male infertility
Abstract Introduction Infertility affects about one in six couples and a male factor may contribute to 50% of cases. Until recently, no Australian‐based clinical guidelines for the management of male infertility had been published. A panel of experts was assembled to formulate the first Australian evidence‐based guidelines on male infertility.
Darren J Katz +6 more
wiley +1 more source
Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
Polycystic ovary syndrome (PCOS) is the commonest endocrinopathy in women that is associated with reproductive and metabolic disorders.We compared the ovulation and conception rates after the treatment with clomiphene citrate (CC) alone and in combination with metformin in infertile patients presented with polycystic ovarian syndrome (PCOS).This ...
Aqueela Ayaz +2 more
openaire +3 more sources
Current Medical Research: Summer–Fall 2009 [PDF]
Note that the “Current Medical Research” feature focuses on issues relevant to natural family planning and the beginning of life. This piece is complemented by medical reviews published in The National Catholic Bioethics Quarterly, which focus more on ...
Fehring, Richard
core +2 more sources
This meta‐analysis of seven RCTs (n = 489) demonstrates that acupuncture significantly improves depression scores, hirsutism, and BMI in PCOS patients, though anxiety symptoms show no significant improvement. Evidence quality is low, warranting cautious interpretation. ABSTRACT Introduction Preliminary studies have indicated that acupuncture may play a
Lanfeng Lai +7 more
wiley +1 more source
BackgroundTo determine whether progestin-primed ovarian stimulation (PPOS) is more effective for women with diminished ovarian reserve (DOR) than clomiphene citrate (CC)/letrozole (LE) plus gonadotropin in IVF or ICSI treatment.MethodsNine databases were
Guangyao Lin +4 more
doaj +1 more source
ABSTRACT Background and Aims Polycystic ovarian syndrome, with a mean incidence of 5–10, is the most common endocrine disorder affecting women of reproductive age. These patients suffer from a wide range of symptoms that are inversely related to their resilience and quality of life.
Soghra Khani +4 more
wiley +1 more source
Pregnancy Rate Following Luteal Phase Support in Iranian Women with Polycystic Ovarian Syndrome [PDF]
Background To assess the efficacy of luteal phase support (LPS) using intravaginal progesterone (P) on pregnancy rate in Iranian women with polycystic ovarian syndrome (PCOS) who used a combination for ovulation induction consisting of letrozole or ...
Fatemeh Foroozanfard +3 more
doaj
Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome [PDF]
BACKGROUND Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes. Full Text of Background...
Alvero, Ruben +22 more
core +2 more sources
Gynecologic surgery for benign disease: Preserving reproductive potential
Abstract Preserving fertility is essential when managing benign gynecologic disorders in reproductive‐aged women. Surgical interventions can impact future fertility, therefore requiring an evidence‐based, individualized approach. The FIGO Committee on Reproductive Endocrinology and Infertility reviewed current literature to develop recommendations for ...
Togas Tulandi +23 more
wiley +1 more source
Demographics, Usage Patterns, and Safety of Male Users of Clomiphene in the United States
Purpose: The aim of this study was to characterize the demographics, usage patterns and complication rates of clomiphene use in male patients. Materials and Methods: We retrospectively analyzed male patients from ages 20 to 55 years old who were ...
David P. Guo +4 more
doaj +1 more source

